tradingkey.logo
tradingkey.logo
Search

Precision BioSciences Inc

DTIL
Add to Watchlist
6.930USD
-0.020-0.29%
Market hours ETQuotes delayed by 15 min
166.93MMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-23
Previous score
9.00
Change
0
The current earnings forecast score of Precision BioSciences Inc is 9.00, ranking 15 out of 389 in the Biotechnology & Medical Research industry. The average price target is 25.50, with a high of 60.00 and a low of 19.00.

Analyst Rating

Based on 5 analysts
Strong Buy
Current Rating
29.600
Target Price
+318.08%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Precision BioSciences Inc
DTIL
5
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
1
2
3
...
112

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Precision BioSciences Inc's expected revenue for the next quarter?

Precision BioSciences Inc's expected revenue is 1.12M.

What is Precision BioSciences Inc's price target?

Analysts forecast that Precision BioSciences Inc's price target is USD 25.50, with the highest forecast at USD 60.00 and the lowest forecast at USD 19.00.

How have Precision BioSciences IncDTIL's recent earnings per share performed?

The market expectation was USD -0.75, while Precision BioSciences IncDTIL's earnings per share (EPS) for the previous quarter was USD 1.05. EPS for the next quarter is expected at USD -0.79.

What is the analyst rating for Precision BioSciences Inc?

Based on the ratings of Precision BioSciences Inc's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI